Zydus Wellness Yönetim

Yönetim kriter kontrolleri 3/4

Zydus Wellness CEO'su Tarun Arora, Jan2019 tarihinde atandı, in görev süresi 5.83 yıldır. in toplam yıllık tazminatı ₹ 11.92M olup, şirket hissesi ve opsiyonları dahil olmak üzere 100% maaş ve 0% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.003% ine doğrudan sahiptir ve bu hisseler ₹ 3.86M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 1.2 yıl ve 8 yıldır.

Anahtar bilgiler

Tarun Arora

İcra Kurulu Başkanı

₹11.9m

Toplam tazminat

CEO maaş yüzdesi	100.0%
CEO görev süresi	5.8yrs
CEO sahipliği	0.003%
Yönetim ortalama görev süresi	1.2yrs
Yönetim Kurulu ortalama görev süresi	8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Tarun Arora'un ücretlendirmesi Zydus Wellness'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 30 2024	n/a	n/a	₹3b
Jun 30 2024	n/a	n/a	₹3b
Mar 31 2024	₹12m	₹12m	₹3b
Dec 31 2023	n/a	n/a	₹3b
Sep 30 2023	n/a	n/a	₹3b
Jun 30 2023	n/a	n/a	₹3b
Mar 31 2023	₹13m	₹13m	₹3b
Dec 31 2022	n/a	n/a	₹3b
Sep 30 2022	n/a	n/a	₹3b
Jun 30 2022	n/a	n/a	₹3b
Mar 31 2022	₹12m	₹12m	₹3b
Dec 31 2021	n/a	n/a	₹3b
Sep 30 2021	n/a	n/a	₹3b
Jun 30 2021	n/a	n/a	₹2b
Mar 31 2021	₹13m	₹13m	₹1b
Dec 31 2020	n/a	n/a	₹547m
Sep 30 2020	n/a	n/a	₹572m
Jun 30 2020	n/a	n/a	₹2b
Mar 31 2020	₹11m	₹11m	₹1b
Dec 31 2019	n/a	n/a	₹1b
Sep 30 2019	n/a	n/a	₹2b
Jun 30 2019	n/a	n/a	₹2b
Mar 31 2019	₹33m	₹33m	₹2b
Dec 31 2018	n/a	n/a	₹1b
Sep 30 2018	n/a	n/a	₹1b
Jun 30 2018	n/a	n/a	₹1b
Mar 31 2018	₹30m	₹30m	₹1b

Tazminat ve Piyasa: Tarun 'nin toplam tazminatı ($USD 141.07K ), Indian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 503.20K ).

Tazminat ve Kazançlar: Tarun 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Tarun Arora (52 yo)

5.8yrs

Görev süresi

₹11,920,000

Tazminat

Mr. Tarun G. Arora has been Chief Executive Officer of Zydus Wellness Limited since January 2019 and is instrumental in accelerating the growth on back of innovations, expanding the geographies for the bus...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Tarun Arora	CEO & Whole Time Director	5.8yrs	₹11.92m	0.0031% ₹ 3.9m
Umesh Parikh	Chief Financial Officer	6.8yrs	₹12.02m	Veri yok
Arijit Sengupta	Chief Marketing Officer	less than a year	Veri yok	Veri yok
Saurabh Jain	Chief Digital Excellence Officer	less than a year	Veri yok	Veri yok
Bhupesh Desale	Head of Neo Foods Vertical	less than a year	Veri yok	Veri yok
Nandish Joshi	Company Secretary	2.3yrs	Veri yok	Veri yok

1.2yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 531335 'un yönetim ekibi deneyimli olarak kabul edilmiyor ( 1.2 yıl), bu da yeni bir ekibin varlığını gösteriyor.

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Tarun Arora	CEO & Whole Time Director	9.5yrs	₹11.92m	0.0031% ₹ 3.9m
Sharvil Patel	Non-Executive Chairman	15.6yrs	₹700.00k	0.00084% ₹ 1.0m
Ganesh Nayak	Non-Executive Director	18.3yrs	₹1.00m	0.010% ₹ 12.6m
Dharmishtaben Raval	Non-Executive Independent Director	5.7yrs	₹1.40m	Veri yok
Kulin Lalbhai	Non-Executive & Independent Director	8yrs	₹1.10m	Veri yok
Akhil Monappa	Additional Non Executive & Independent Director	1.5yrs	₹1.20m	Veri yok
Srivishnu Nandyala	Non-Executive Independent Director	5.7yrs	₹1.50m	Veri yok

8.0yrs

Ortalama Görev Süresi

51yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 531335 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8 yıldır).

Zydus Wellness Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Zydus Wellness Limited Announces Executive Appointments

Zydus Wellness Limited Announces Resignation of Ashish P. Bhargava as Nominee Director

Zydus Wellness Limited, Annual General Meeting, Aug 02, 2024

Insider recently bought ₹175m worth of stock

Zydus Wellness Limited Announces Resignation of Savyasachi Sengupta as Independent Director

Insider recently bought ₹331m worth of stock

Recent updates

Second quarter 2025 earnings released: EPS: ₹3.28 (vs ₹0.93 in 2Q 2024)

Zydus Wellness Limited (BSE:531335) signed a letter of intent to acquire Naturell India Private Limited for INR 3.9 billion.

Zydus Wellness Limited Announces Executive Appointments

Zydus Wellness Limited Announces Resignation of Ashish P. Bhargava as Nominee Director

Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2024

Price target increased by 15% to ₹2,160

Full year 2024 earnings: EPS misses analyst expectations

Zydus Wellness Limited to Report Q3, 2025 Results on Feb 14, 2025

Investor sentiment improves as stock rises 17%

Price target increased by 8.2% to ₹1,883

Dividend of ₹5.00 announced

Zydus Wellness Limited, Annual General Meeting, Aug 02, 2024

Full year 2024 earnings: EPS misses analyst expectations

Zydus Wellness Limited Recommends Final Dividend, Payable on or After August 7, 2024

Zydus Wellness Limited to Report Q4, 2024 Results on May 14, 2024

Insider recently bought ₹175m worth of stock

Consensus EPS estimates fall by 15%

Third quarter 2024 earnings released: EPS: ₹0.05 (vs ₹3.07 in 3Q 2023)

Zydus Wellness Limited to Report Q3, 2024 Results on Feb 08, 2024

Second quarter 2024 earnings released: EPS: ₹0.93 (vs ₹1.33 in 2Q 2023)

Zydus Wellness Limited Announces Resignation of Savyasachi Sengupta as Independent Director

Zydus Wellness Limited to Report Q2, 2024 Results on Nov 06, 2023

Insider recently bought ₹331m worth of stock

Zydus Wellness Limited Approves Final Dividend for the Financial Year Ended March 31, 2023

New minor risk - Dividend sustainability

Zydus Wellness Limited to Report Q1, 2024 Results on Aug 03, 2023

Upcoming dividend of ₹5.00 per share at 0.3% yield

Full year 2023 earnings: EPS misses analyst expectations

Insider recently bought ₹385m worth of stock

Insider recently bought ₹148m worth of stock

Price target decreased by 7.4% to ₹1,813

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Zydus Wellness Limited Appoints Akhil Monappa as Additional Director (Non Executive & Independent Director)

Full year 2023 earnings: EPS misses analyst expectations

Zydus Wellness Limited, Annual General Meeting, Aug 03, 2023

Insider recently bought ₹1.8m worth of stock

Third quarter 2023 earnings released: EPS: ₹3.07 (vs ₹3.66 in 3Q 2022)

CEO & Whole Time Director recently bought ₹301k worth of stock

Second quarter 2023 earnings released: EPS: ₹1.33 (vs ₹3.37 in 2Q 2022)

Insider recently bought ₹16m worth of stock

Insider recently bought ₹9.2m worth of stock

Zydus Wellness Limited Declares Final Dividend for the Financial Year Ended March 31, 2022

Zydus Wellness Limited Appoints Nandish P. Joshi as the Company Secretary

Upcoming dividend of ₹5.00 per share

Zydus Wellness Limited to Report First Half, 2023 Results on Nov 14, 2022

Insider recently bought ₹55m worth of stock

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Zydus Wellness Limited Recommends Final Dividend for the Year Ended on March 31, 2022, Payable on or After August 4, 2022

Consensus forecasts updated

Zydus Wellness Limited, Annual General Meeting, Jul 29, 2022

Price target decreased to ₹2,125

Insufficient new directors

Price target decreased to ₹2,125

Insufficient new directors

Insider recently bought ₹757k worth of stock

Zydus Wellness Limited Announces Resignation of Dhanraj P. Dagar as Company Secretary & Compliance Officer, Effective May 10, 2022

Consensus EPS estimates fall by 10%

Price target decreased to ₹2,339

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

CEO & Whole Time Director recently bought ₹812k worth of stock

Second quarter 2022 earnings released: EPS ₹3.37 (vs ₹18.14 loss in 2Q 2021)

Insider recently sold ₹2.3m worth of stock

Price target increased to ₹2,517

Upcoming dividend of ₹5.00 per share

Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020)

Full year 2021 earnings released: EPS ₹19.55 (vs ₹24.58 in FY 2020)

Zydus Wellness Limited Recommends Final Dividend

Price target raised to ₹2,266

Third quarter 2021 earnings released: EPS ₹0.27 (vs ₹0.73 in 3Q 2020)